可行性研究 - 过滤器通风
2026年9月8日 更新者:Masonic Cancer Center, University of Minnesota
进行一项远程医疗研究的可行性,评估去除过滤通风对吸烟行为和生物标志物的影响
这项开放标签、受试者间、随机多中心试点研究将评估通过远程医疗访问进行远程研究的可行性,以评估过滤嘴通风最少的香烟与中等过滤嘴通风对吸烟行为和烟草毒物暴露生物标志物的影响.
将远程收集每天的主观测量值、肺泡一氧化碳、血压和香烟。
生物样本将在家中收集并邮寄到研究诊所。
研究概览
地位
完全的
条件
详细说明
符合资格标准的传统卷烟通风量约为 16-30% 的卷烟吸烟者将进入 3 周的常规品牌吸烟监测。
然后,将在 6 周的时间内将受试者随机分配到以下两种情况之一:1) 通风香烟;或 2) 未通风的香烟。
每种情况下的受试者都将被揭盲以模拟真实世界的情况。
向受试者提供一张借记卡 (ClinCard),该卡已加载适当金额以支付基线时自购的普通品牌香烟和干预期间指定的研究香烟。
每周远程医疗访问将在基线和研究香烟的 6 周内进行,以收集研究措施,然后进行一个月的随访。
研究类型
介入性
注册 (实际的)
46
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Minnesota
-
Minneapolis、Minnesota、美国、55405
- University of Minnesota
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
21年 及以上 (成人、年长者)
接受健康志愿者
不
描述
纳入标准:
- 21岁或以上
- 经常吸烟的人
- 目前吸食符合条件的品牌
- 身体状况一般
- 使用智能手机或平板电脑以及带有功能摄像头的设备进行远程医疗访问。 还必须能够访问互联网。
排除标准:
- 健康不稳定
- 不受控制的高血压
- 怀孕或哺乳
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Menthol Cigarette Smokers Group 1
Smokers regularly using menthol cigarettes (at least 80% of the time ) who meet eligibility criteria will enter 2 weeks of monitoring of usual brand smoking.
Randomized to ventilated non-menthol cigarettes.
|
4 week intervention where participants will be using ventilated non-menthol cigarettes. Weekly telehealth visits will be conducted during baseline and the 4 weeks on study cigarettes to collect study measures followed by a follow-up one month after end of intervention. |
|
有源比较器:Menthol Cigarettes Smokers Group 2
Smokers regularly using menthol cigarettes (at least 80% of the time ) who meet eligibility criteria will enter 2 weeks of monitoring of usual brand smoking.
Randomized to minimally ventilated non-menthol cigarettes.
|
4 week intervention where participants will be using minimally ventilated non-menthol cigarettes. Weekly telehealth visits will be conducted during baseline and the 4 weeks on study cigarettes to collect study measures followed by a follow-up one month after end of intervention. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Percentage of Participants That Dropped Out
大体时间:Baseline through Week 4
|
Percentage of Participants that dropped out by week 4.
|
Baseline through Week 4
|
|
Feasibility of Approach - Data Collection
大体时间:Baseline through Week 4
|
Percent reporting difficulty collecting data in the Study Feasibility Questionnaire and interview
|
Baseline through Week 4
|
|
Cigarettes Smoked Per Day
大体时间:Baseline through Week 4
|
Change in mean Cigarettes Per Day (CPD) based on 7 day ITR data before visit.
Randomized participants (low vs moderate FV), between-group difference in change in cigarettes per day from baseline to Week 4, comparing low-ventilated versus moderate-ventilated non-menthol cigarette groups.
Cigarettes per day (CPD) was calculated as the mean number of cigarettes smoked per day based on daily self-reported cigarette use collected via interactive text response (ITR) surveys.
Change scores were computed as the difference between the mean CPD at Week 4 and the mean CPD at baseline for each participant, and group differences reflect the between-arm difference in these change scores.
|
Baseline through Week 4
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Cotinine Change
大体时间:Baseline through week 4
|
Change in cotinine from baseline to the week 4 visit.
Randomized participants (low vs moderate FV), between-group difference in cotinine from baseline to Week 4, comparing low-ventilated versus moderate-ventilated non-menthol cigarette groups.
Cotinine was measured from blood samples collected using volumetric absorptive micro sampling (VAMS) and analyzed using liquid chromatography-mass spectrometry.
Due to skewness, cotinine values were log-transformed, and change was calculated as the log ratio of Week 4 to baseline levels.
Group differences represent the between-arm difference in these log-transformed changes.
|
Baseline through week 4
|
|
Carbon Monoxide Changes
大体时间:Baseline through Week 4
|
Change in Carbon Monoxide from baseline to the week 4 visit.
Randomized participants (low vs moderate FV), between-group difference in carbon monoxide from baseline to Week 4, comparing low-ventilated versus moderate-ventilated non-menthol cigarette groups.
Exhaled carbon monoxide (ppm) was measured remotely using a portable CO monitor during scheduled study visits.
Change scores were calculated as Week 4 minus baseline CO levels for each participant, and group differences represent the between-arm difference in these change scores.
|
Baseline through Week 4
|
|
Quit Attempts
大体时间:Baseline through Week 4
|
Number of 24 hour quit attempts analyzed using regression estimate.
Randomized participants (low vs moderate FV), between-group difference in quit attempt from baseline to Week 4, comparing low-ventilated versus moderate-ventilated non-menthol cigarette groups.
|
Baseline through Week 4
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Dorothy Hatsukami, PH.D、Masonic Cancer Center, University of Minnesota
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2024年3月18日
初级完成 (实际的)
2025年6月5日
研究完成 (实际的)
2025年6月30日
研究注册日期
首次提交
2020年8月12日
首先提交符合 QC 标准的
2020年8月12日
首次发布 (实际的)
2020年8月17日
研究记录更新
最后更新发布 (实际的)
2026年9月9日
上次提交的符合 QC 标准的更新
2026年9月8日
最后验证
2026年9月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.